Document text
Draft Agenda
10:00 Welcome and Roll Call Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
10:20 Update on Work Groups TBD
11:00 COVID-19 Vaccines
Introduction TBD
COVID-19 epidemiology Dr. Adam MacNeil (CDC/NCIRD)
COVID-19 vaccine effectiveness update Dr. Adam MacNeil (CDC/NCIRD)
COVID-19 safety update TBD
COVID-19 vaccine coverage and implementation Dr. Georgina Peacock (CDC/NCIRD)
Evidence to recommendations (partial) Dr. Adam MacNeil (CDC/NCIRD)
1:00 Lunch
1:30 Agency Updates CDC, CMS, FDA, HRSA, IHS, NIH
2:00 RSV Vaccines- Maternal/Pediatric
Introduction TBD
Updates on uptake of maternal vaccine and nirsevimab Dr. Georgina Peacock (CDC/NCIRD)
Updates on the impact and epidemiology of maternal vaccine and
nirsevimabDr. Adam MacNeil (CDC/NCIRD)
Updates on the effectiveness of maternal vaccine and nirsevimab Dr. Adam MacNeil (CDC/NCIRD)
Updates on safety of maternal vaccine and nirsevimab TBD
Updates and summary of the Evidence to Recommendation
Framework for clesrovimabDr. Adam MacNeil (CDC/NCIRD)
Updates on clinical considerations for clesrovimab Dr. Adam MacNeil (CDC/NCIRD)
Proposed Recommendations Dr. Adam MacNeil (CDC/NCIRD)
Updates to RSV vaccines VFC resolution Dr. Georgina Peacock (CDC/NCIRD)
4:00 Break
4:15 Public Comment
5:00 Votes
RSV Vaccines- Maternal/Pediatric Dr. Adam MacNeil (CDC/NCIRD)
RSV Vaccines- VFC Dr. Georgina Peacock (CDC/NCIRD)
5:30 AdjournMEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Centers for Disease Control and Prevention
Atlanta, Georgia 30329
Wednesday, June 25, 2025
Draft Agenda
8:00 Welcome and Roll Call Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
8:15 Influenza Vaccines
Introduction TBD
Flublok in older children and adolescents: immunogenicity and safety Dr. Pedro Folegatti (Sanofi Pasteur)
Estimates of influenza burden and burden averted through vaccination Dr. Vivien Dugan (CDC/NCIRD)
Proposed recommendations for 2025-26 Dr. Vivien Dugan (CDC/NCIRD)
Presentation regarding thimerosal in vaccines TBD
Proposed recommendations regarding thimerosal containing influenza
vaccineTBD
10:15 Break
10:30 Chikungunya Vaccines
Introduction TBD
EtR (partial) for use of live attenuated and virus-like particle
chikungunya
vaccines in U.S territoriesDr. Lyle Peterson (CDC/NCEZID)
Safety update on live attenuated chikungunya vaccine and use among
older personsDr. Lyle Peterson (CDC/NCEZID)
10:45 Anthrax Vaccine Dr. Brenden Jackson (CDC/NCEZID)
10:50 MMRV Vaccine
TBD Presentation on MMRV vaccine in children under under 4 years
of age
Proposed recommendations regarding MMRV in children under
4 years of ageTBD
11:20 Break
11:30 Public Comment
12:15 Break
12:30 Votes
Influenza Vaccines Dr. Vivien Dugan (CDC/NCIRD)
Thimerosal containing influenza vaccine recommendations TBD
1:00 Adjourn
Acronyms
CDC Centers for Disease Control and Prevention
CMS Centers for Medicare & Medicaid Services
COVID-19 Coronavirus disease 2019
EtR Evidence to Recommendations Framework
FDA Food and Drug Administration
HRSA Health Resources and Services Administration
IHS Indian Health Service
MMRV Measles, Mumps, Rubella, Varicella Vaccine
NCIRD National Center for Immunization & Respiratory Diseases
NCEZID National Center for Emerging and Zoonotic Diseases
NIH National Institutes of Health
RSV Respiratory Syncytial Virus
VFC Vaccines for ChildrenThursday, June 26, 2025